[12]Yoshida H，Hamano S，Senaldi G，et al．WSX-1 isrequired for the in itiation of Th1 responses and resistance to IL-27[J]．major infection Immunity，2001，15：569-578．

[13]Pan HF，Tao JH，Ye DQ.Therapeutic potential of IL-27 in systemic lupus erythematosus[J].Expert Opin Ther Targets，2010，14(5)：479-484.

[14]Villarino A，ibbert L，Liebennan L，et al.The IL-27R is required to suppress T cell hyper activity during infection[J].Immunity，2003，19(5)：645-655．

[15]Sugiyama N，Nakashima H，Yoshimura T，et al.Amelioration of human lupus-like phenotypes in MRL/lprmice by overexpression of interleukin-27 receptor alpha (WSX-1)[J].Ann Rheum Dis，2008，67(10)：1461-1467.

[16]Liu H，Rohowsky-Kochan C.Interleukin-27-mediated suppression of human Th17 cells is associated with activation of STAT1 and suppressor of cytokine signaling protein 1[J].J Interferon Cytokine Res，2011，31(5)：459-469.

[17]Porcel JM.Advances in the diagnosis of tuberculous pleuritis[J].Ann Transl Med，2016，4(15)：282.